Lipid profile and apolipoprotein E polymorphism in essential hypertension

Indian Heart Journal

Volumn 57, Issue 2, 2005, Pages 151-157

  Bhavani, A B ^a   Sastry, K B ^a   Reddy, N Krishna ^a   Padma, T ^a  

^a OSMANIA UNIVERSITY   (India)

Author keywords

Apolipoprotein E polymorphism; Dyslipidemia; Essential hypertension

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DNA; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LEUKOCYTES; LIPIDS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TRIGLYCERIDES;

EID: 22244433171     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Singh RB, Bajaj S, Niaz MA, Rastogi SS, Moshiri M. Prevalence of type 2 diabetes mellitus and risk of hypertension and coronary artery disease in rural and urban population with low rates of obesity. Int J Cardiol 1998; 66: 65-72
2. Reddy NK, Kumar DN, Rayudu NV, Sastry BK, Raju BS. Prevalence of risk factors for coronary atherosclerosis in a cross-sectional population of Andhra Pradesh. Indian Heart J 2002; 54: 697-701
3. Gupta R, Gupta VP, Sarna M, Bhatnagar S, Thanvi J, Sharma V, et al. Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-2. Indian Heart J 2002; 54: 59-66
4. WHO - International Society of Hypertension: Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151-183
5. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA 2003; 289: 2560-2572
6. Heart and stroke facts. The American Heart Association. 2003. http// www.americanheart.org
7. The National High Blood Pressure Education Program Working Group. Report on hypertension in diabetes. Hypertension 1994; 23: 145-158
8. Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. BMJ 2004; 328: 807-810
9. North KE, Howard BV, Welty TK, Best LG, Lee ET, Yeh JL, et al. Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study. Am J Epidemiol 2003; 157: 303-314
10. Friedlander Y, Arbogast P, Schwartz SM, Marcovina SM, Austin MA, Rosendaal FR, et al. Family history as a risk factor for early onset myocardial infarction in young women. Atherosclerosis 2001; 156: 201-207
11. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987; 113: 433-440
12. Karvonen J, Kauma H, Kervinen K, Ukkola O, Rantala M, Paivansalo M, et al. Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men. J Hypertens 2002; 20: 2371-2378
13. Kolovou G, Daskalova D, Mikhailidis DP. Apolipoprotein E polymorphism and atherosclerosis. Angiology 2003; 54: 59-71
14. Mahley RW, Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-630
15. Siest G, Pillot T, Régis-Bailly A, Leininger-Muller B, Steinmetz J, Galteau MM, et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 1995; 41: 1068-1086
16. Paik YK, Chang DJ, Reardon CA, Davies GE, Mahley RW, Taylor JM. Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci USA 1985; 82: 3445-3449
17. Das HK, Mcpherson J, Bruns GA, Karathanasis SK, Breslow JL. Isolation, characterization and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem 1985; 260: 6240-6247
18. Lusis AJ, Heinzmann C, Sparkes RS, Scott J, Knott TJ, Geller R, et al. Regional mapping of human chromosome 19: organization of genes for plasma lipid transport (Apo C1, C2, E and LDLR) and the genes C3, PEPD, and GPI. Proc Natl Acad Sci USA 1986; 83: 3929-3933
19. Smit M, von der Kooij-Meijis E, Frants RR, Havekes L, Klasen EC. Apolipoprotein gene cluster on chromosome 19. Definite localization of the apo C2 gene and the polymorphic Hpa I site associated with type III hyperlipproteinemia. Hum Genet 1988; 78: 90-93
20. Rall SC, Weisgraber KH, Mahley RW. Human apolipoprotein E. The complete amino acid sequence. J Biol Chem 1982;257:4171-4178
21. Utermann G, Largenbeck U, Beisiegel U, Weber W. Genetics of the apolipoprotein E system in man. Am J Hum Genet 1980; 32 339-347
22. Zannis VI, and Breslow JL. Human very low density lipoprotein E isoprotein polymorphism is explained by genetic variation and post-translational modification. Biochemistry 1981; 20: 1033-1041
23. Weisgraber KH, Rall SC Jr, Mahley RW. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequences of the apo E isoforms. J Biol Chem 1981; 256: 9077-9083
24. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 2002; 155: 487-495
25. Breslow JL. Apolipoprotein genetic variation and human disease. Physiol Rev 1988; 68: 85-98
26. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991; 49: 338-349
27. Davignon J. Apolipoprotein E polymorphism and atherosclerosis. In: Born GVR Schwartz CJ (eds). New Horizons in Coronary Heart Disease. Curr Sci 1993; 5: 5.1-5.21
28. Boerwinkle E, Visvikis S, Welsh D, Steinmetz J, Hanash SM, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and co-variability of cholesterol, beta lipoprotein, and triglycerides in a sample of unrelated individuals. Am J Med Genet 1987; 27: 567-582
29. Breslow JL, Zannis VI, San Giacomo TR, Third JL, Tracy T, Glueck CJ. Studies of familial type III hyperlipoproteinemia using as a genetic marker the apo E phenotype E2/2. J lipid Res 1982; 23: 1224-1235
30. Weisgraber KH, Innerarity TL, Mahley RW. Abnormal lipoprotein receptor binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem 1982; 257: 2518-2521
31. Friedewald WT, Lavy RI Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
32. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215
33. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 1990; 31: 545-548
34. Wolf G. On estimating the relationship between blood group and disease. Ann Hum Genet 1995; 19: 252-253
35. Venkataramana P, Chengal Reddy, Ferrell RE. Apolipoprotein E polymorphism in two populations of Andhra Pradesh. Ind J Hum Genet 2002; 3: 1-5
36. Utermann G, Hardewig A, Zimmer F. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet 1984; 65: 237-241
37. Lehtinen S, Lehtimäki T, Sisto T, Salenius JP, Nikkilä M, Jokela H, et al. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis 1995; 114: 83-91
38. Dembinska-Kiec A, Kawecka-Jaszcz K, Kwasniak M, Guevaro I, Pankiewicz J, Malczewslea-Malec M, et al. Apo E isoforms, insulin output and plasma lipid levels in essential hypertension. Eur J Clin Invest 1998; 28: 95-99
39. Yilmaz H, Isbir T, Agachan B, Aydin M. Is epsilon 4 allele of apolipoprotein E associated with more severe end-organ damage in essential hypertension? Cell Biochem Funct 2001; 19: 191-195
40. Li X, Du Y, Du Y, Huang X. Association of apolipoprotein E gene polymorphism with essential hypertension and its complications. Clin Exp Med 2003; 2: 175-179
41. Couderc R, Mahieux F, Bailleul S, Fenelon G, Mary R, Fermanlan J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. Stroke 1993; 24: 661-664
42. Katsuya T, Baba S, Ishikawa K, Mannami T, Fu Y, Inamoto N, et al. Epsilon 4 allele of apolipoprotein E gene associates the lower blood pressure in young Japanese subjects. J Hypertens 2002; 20: 2017-2021
43. Rastas S, Mattila K, Verkkoniemi A, Niinistö L, Juva K, Sulkav R, et al. Association of apolipoprotein E genotypes, blood pressure, blood lipids and ECG abnormalities in a general population aged 85+. BMC Geriatr 2004; 4: 1
44. Sowers JR. Hypertension in the elderly. Am J Med 1987; 82: 1-8
45. Laws SM, Hone E, Gandy S, Martins RN. Expanding the association between the apo E gene and risk of Alzheimer's disease: possible roles for apo E promoter polymorphism and alternation in Apo E transcription. J Neurochem 2003; 84: 1215-1236
46. de Knijff P, Havekes LM. Apolipoprotein E as a risk factor for coronary heart disease: a genetic and molecular biology approach. Curr Opin Lipidol 1996; 7: 59-63
47. Simopoulos AP. Genetic variation and nutrition. Word Rev Nutr Diet 1999; 84: 118-140
48. de Andrade M, Thandi I, Brown S, Gotto A, Patsch W, Boerwinkle E. Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. Am J Hum Genet 1995; 56: 1379-1390
49. Cattin L, Fisicaro M, Tonizzo M, Valenti M, Danek GM, Fonda M, et al. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults. Arterioscler Thromb Vasc Biol 1997: 1-94
50. Terry JG, Howard G, Mercuri M, Bond MG, Crouse JR. Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima-media thickening. Stroke 1996; 27: 1755-1759
51. Kardia SL, Haviland MB, Ferrell RE, Sing CF. The relationship between risk factor levels and presence of coronary artery calcification is dependent on apolipoprotein E genotype. Arterioscler Thromb Vasc Biol 1999; 19: 427-435
52. Zerba KE, Ferrell RE, Sing CF. Genotype-environment interaction: apolipoprotein E gene effects and age as an index of time and spatial context in humans. Genetics 1996; 143: 463-478
53. Reilly S, Ferrell R, Kottke B, Kamboh MI, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances. Am J Hum Genet 1991; 49: 1155-1166
54. Reilly S, Ferrell R, Kottke B, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN. II. Regression relationships with concomitants. Am J Hum Genet 1992; 51: 1311-1324
55. Reilly S, Ferrell R, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN. III. Correlations and covariances. Am J Hum Genet 1994; 55: 1001-1018